Rockwell Automation Helps Customers Unlock the Potential of Their Data with the Launch of OptixEdge
Advanced edge gateway solution transforms the way data is processed, enabling time and cost savings
MILWAUKEE, Wis., June 12, 2025 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced the global launch of OptixEdge, an innovative edge gateway solution that revolutionizes data processing for industrial customers.
Today's smart machines are generating more data than ever, but according to Rockwell's latest State of Smart Manufacturing Report, only 44% of data is being used effectively. Many companies face challenges that prevent them from utilizing a vast amount of their data, such as network limitations, security concerns, or storage costs. Traditionally, data is sent to distant cloud servers to be processed, but this can be expensive and inefficient.
OptixEdge can directly address these issues by processing information where it's created – at the machine, in real time. It connects to the user's control system through Rockwell's FactoryTalk® Optix™ software to collect, analyze, and send data to the cloud, enabling users to monitor and analyze machine or system data from multiple locations. This means faster insights, lower costs, and smarter decision-making.
"OptixEdge empowers customers to take control of their data like never before, providing powerful edge computing capabilities with flexibility, security, and ease of use," said Jessica Morell, software product manager at Rockwell Automation. "By processing data at its source, OptixEdge enables customers to unlock valuable insights, improve efficiency, and drive innovation across their operations."
Key capabilities of OptixEdge include:
Rockwell's website.
About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK) is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
a day ago
- Korea Herald
Rockwell Automation Helps Customers Unlock the Potential of Their Data with the Launch of OptixEdge
Advanced edge gateway solution transforms the way data is processed, enabling time and cost savings MILWAUKEE, Wis., June 12, 2025 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced the global launch of OptixEdge, an innovative edge gateway solution that revolutionizes data processing for industrial customers. Today's smart machines are generating more data than ever, but according to Rockwell's latest State of Smart Manufacturing Report, only 44% of data is being used effectively. Many companies face challenges that prevent them from utilizing a vast amount of their data, such as network limitations, security concerns, or storage costs. Traditionally, data is sent to distant cloud servers to be processed, but this can be expensive and inefficient. OptixEdge can directly address these issues by processing information where it's created – at the machine, in real time. It connects to the user's control system through Rockwell's FactoryTalk® Optix™ software to collect, analyze, and send data to the cloud, enabling users to monitor and analyze machine or system data from multiple locations. This means faster insights, lower costs, and smarter decision-making. "OptixEdge empowers customers to take control of their data like never before, providing powerful edge computing capabilities with flexibility, security, and ease of use," said Jessica Morell, software product manager at Rockwell Automation. "By processing data at its source, OptixEdge enables customers to unlock valuable insights, improve efficiency, and drive innovation across their operations." Key capabilities of OptixEdge include: Rockwell's website. About Rockwell Automation Rockwell Automation, Inc. (NYSE: ROK) is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit
Korea Herald
3 days ago
- Korea Herald
Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics
- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs. SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical gains access to Salipro Biotech's expertise and Salipro® platform for stabilizing challenging membrane proteins (e.g., GPCRs, ion channels, transporters). The collaboration will target a specific membrane protein to aid Daewoong's development of novel small molecule drugs. Under the terms of this agreement, the collaboration will enable Daewoong Pharma to leverage Salipro Biotech´s expertise and proprietary platform to advance their drug discovery efforts in the development of novel therapeutic small molecules against a challenging membrane protein drug target. "We are excited to join forces with Daewoong Pharmaceutical and contribute with our proprietary Salipro® platform to accelerate the development of novel therapeutic drugs for Daewoong Pharmaceutical's pipeline", said Jens Frauenfeld, CEO of Salipro Biotech. "This partnership is particularly significant as it marks our first collaboration with a partner in South Korea, underscoring the global application and versatility of our expertise and platform to make the undruggable druggable." Seongsoo Park, CEO at Daewoong Pharmaceutical stated, "Collaborating with Salipro Biotech and accessing their Salipro® platform aligns with our goal to address complex drug targets. Salipro's expertise in membrane protein stabilization will benefit our research for novel small molecule therapeutics, and we look forward to the results of our joint efforts." About Salipro Biotech AB Salipro Biotech AB is a privately held biotech company focused on unlocking challenging drug targets for the development of next-generation therapeutics. The company is headquartered in Stockholm, Sweden with a fully owned IP portfolio that covers the Salipro® platform technology for the stabilization of membrane proteins. The majority of drug targets are so-called membrane proteins; however, these targets are inherently unstable and challenging to investigate. The proprietary Salipro® technology stabilizes membrane proteins in their native forms, enabling them to be employed in drug discovery programs for therapeutic antibodies, small molecule drugs and structure-based drug design. To date, Salipro Biotech has signed multiple research collaborations with top-tier pharma and biotech companies. Through in-house and partnered pipelines, Salipro Biotech AB accelerates the discovery of novel drugs. About Daewoong Pharmaceutical Daewoong Pharmaceutical (KRX: established in 1945, is a global pharmaceutical company based in South Korea. The company is committed to the development, manufacturing, and commercialization of pharmaceutical products, with a mission to provide the most beneficial total solutions, including pharmaceuticals and services, which contribute to improving the quality of life of valued consumers. Operating with a keen focus on both domestic and international markets, Daewoong Pharmaceutical specializes in developing treatments for intractable and rare diseases. The company's diverse portfolio encompasses novel drugs, biologics, new products, and C&D, all supported by in-house research and development, open collaboration, and advanced manufacturing facilities. Marking significant achievements in drug development, Daewoong Pharmaceutical has successfully developed novel drugs for GERD, featuring the active ingredient Fexuprazan, and for Type 2 diabetes, with the active ingredient Enavogliflozin, in two consecutive years. The company is currently advancing in the development of First-in-Class Oral Anti-Fibrotic Agent for Idiopathic Pulmonary Fibrosis, utilizing Bersiporocin as a PRS Inhibitor. Notably, Bersiporocin has been designated by the U.S. FDA as an orphan drug and a Fast Track development product.
Korea Herald
3 days ago
- Korea Herald
T.D. Williamson Announces Strategic Investment from Apollo Funds
TULSA, Okla., June 11, 2025 /PRNewswire/ -- T.D. Williamson ("TDW"), a global leader in pipeline infrastructure technology and services, announced today a strategic investment from funds managed by Apollo (NYSE: APO) (the "Apollo Funds"). SCF Partners, a Houston-based private equity firm specializing in energy & infrastructure services investments that acquired TDW in June 2022, will continue to retain a majority ownership stake. TDW has been a leader in the pipeline maintenance and integrity industry for over 100 years. The company offers a comprehensive suite of maintenance and asset optimization solutions that enhance safety, reliability, and performance throughout the full lifecycle of pipeline infrastructure. A recognized technology leader, TDW holds more than 500 registered patents, including innovations in advanced isolation, integrated pigging, in-line integrity assessment and repair — deployed across both infrastructure and utility end markets. Bob McGrew, CEO of TDW, said, "At TDW, we are committed to delivering best-in-class, technically differentiated solutions to support the evolving needs of the operators of critical pipeline infrastructure. This investment by Apollo Funds, alongside our existing relationship with SCF Partners, marks a significant milestone in our journey as we continue to invest in meeting the needs of our customers through innovation and expanding our global reach." Scott Browning, Partner at Apollo, said, "TDW has a long track record of innovation and serving customers across the pipeline industry value chain. We look forward to supporting TDW management and SCF to accelerate strategic growth initiatives that contribute to the safety, reliability and efficiency of energy infrastructure to help serve global energy demand trends." "For over a century, TDW has stood at the forefront of pipeline integrity and innovation," commented Deviyani Misra-Godwin, Managing Director at SCF. "Over the past three years, we've seen tremendous growth in the company, with the team expanding its technology and product portfolio, deepening customer relationships, and continuing to lead the way on safety and operational excellence. We're honored to continue to work alongside TDW's world-class team and excited to welcome Apollo Funds as a strategic partner in this next chapter of growth." TDW and SCF Partners were advised by Vinson & Elkins LLP, while Kirkland & Ellis LLP advised the Apollo Funds. About T.D. Williamson T.D. Williamson ("TDW") serves the gathering, transmission, and distribution sectors of the pipeline industry with a global portfolio of products and services, including advanced isolation, integrated pigging, integrity assessment and repair solutions. With both onshore and offshore applications, TDW offers expansive pipeline maintenance and asset optimization activities. TDW cultivates long-term relationships with pipeline operators that endure throughout the life of a pipeline. To learn more, visit About Apollo Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2025, Apollo had approximately $785 billion of assets under management. To learn more, please visit About SCF Partners Founded in 1989, SCF provides equity capital and strategic growth assistance to build and grow leading energy service, equipment, and technology companies that operate throughout the world. SCF has invested in more than 80 platform companies, made more than 370 additional acquisitions, and developed 18 publicly listed energy service and equipment companies over its history. The firm is headquartered in Houston, Texas, and has offices in Aberdeen and Australia. For more information, please visit
